Adherium (ASX:ADR) said it has received firm commitments for AU$2.6 million convertible notes to support the roll-out of its proprietary Hailie Smartinhaler platform in the US, according to a Tuesday Australian bourse filing.
The capital raise is expected to issue 2.6 million convertible notes maturing in nine months at an interest of 10% per year. Participants will also receive one attached option per two shares subscribed.
PAC Partners and Stralis Capital were the joint lead managers for the capital raise.
The company reaffirmed its guidance to onboard another 1,800 active patients during the next six months and 9,000 active patients by the end of the year.
Its shares rose 10% on market close.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。